Patient Identification for Metastatic CRPC Treatment

Metastatic CRPC Is Common

Most men with castrate-resistant prostate cancer (CRPC) will eventually develop metastatic disease.1-3

Learn more about diagnosing mCRPC

PROVENGE Treatment Window

In the newly metastatic CRPC patient who is asymptomatic or minimally symptomatic, there’s a PROVENGE window.

Learn more about the PROVENGE treatment window

For the Newly Metastatic CRPC Patient

61% of men are PROVENGE-eligible at diagnosis of metastatic CRPC.4

Identify PROVENGE patients

Discuss PROVENGE With Your Patients

Help your patients understand treatment with PROVENGE.

Talk with your patients

REFERENCES:
  1. Hotte SJ, Saad F. Current management of castrate-resistant prostate cancer. Current Oncology. 2010;17(S2):S72-S79.
  2. National Comprehensive Cancer Network. Prostate Cancer. NCCN Clinical Practice Guidelines in Oncology. Version 1.2013. 1/20/13.
  3. Kirby M, Hirst C, Crawford ED. Characterising the castration-resistant prostate cancer population: a systematic review. Int J Clin Pract. 2011;65(11):1180-1192.
  4. Data on file. Dendreon Corporation.
Next : Diagnosing mCRPC

This site is intended for US Health Care Professionals only.

IMPORTANT SAFETY INFORMATION
PROVENGE is intended solely for autologous use and is not routinely tested for transmissible infectious diseases.

In controlled clinical trials, serious adverse events reported in the PROVENGE group included acute infusion reactions (occurring within 1 day of infusion) and cerebrovascular events. Severe (Grade 3) acute infusion reactions were reported in 3.5% of patients in the PROVENGE group. Reactions included chills, fever, fatigue, asthenia, dyspnea, hypoxia, bronchospasm, dizziness, headache, hypertension, muscle ache, nausea, and vomiting. No Grade 4 or 5 acute infusion reactions were reported in patients in the PROVENGE group.

The most common adverse events (incidence ≥ 15%) reported in the PROVENGE group were chills, fatigue, fever, back pain, nausea, joint ache, and headache.

Please see the Full Prescribing Information.

Back to top

 

You are now leaving PROVENGEhcp.com. We are not responsible for content on the third-party Web site to which you will be going. Please review our Web site Terms of Use and Privacy Policy for further information.

Continue Cancel

PROVENGEhcp.com

This content is intended for US health care professionals only and by clicking YES I am confirming that I am a health care provider.

Yes Go to PROVENGE.com